オープン アクセスを義務付けられた論文 - Brian K Flesner詳細
一般には非公開: 1 件
Immunological responses and clinical outcomes in pet dogs with osteosarcoma receiving standard of care therapy and a recombinant Listeria vaccine expressing HER2/neu
NJ Mason, L Selmic, A Ruple, CA London, L Barber, K Weishaar, JA Perry, ...
Molecular Therapy, 2024
委任: US National Institutes of Health
一般公開: 5 件
Clinical validation of a next-generation sequencing-based multi-cancer early detection “liquid biopsy” blood test in over 1,000 dogs using an independent testing set: The …
A Flory, KM Kruglyak, JA Tynan, LM McLennan, JM Rafalko, PC Fiaux, ...
PLoS One 17 (4), e0266623, 2022
委任: US National Institutes of Health
Adjuvant sirolimus does not improve outcome in pet dogs receiving standard-of-care therapy for appendicular osteosarcoma: a prospective, randomized trial of 324 dogs
AK LeBlanc, CN Mazcko, A Cherukuri, EP Berger, WC Kisseberth, ...
Clinical Cancer Research 27 (11), 3005-3016, 2021
委任: US National Institutes of Health
Phase I-II clinical trial of hyaluronan-cisplatin nanoconjugate in dogs with naturally occurring malignant tumors
S Cai, T Zhang, WC Forrest, Q Yang, C Groer, E Mohr, DJ Aires, ...
American journal of veterinary research 77 (9), 1005-1016, 2016
委任: US National Institutes of Health
Comparative oncology assessment of a novel inhibitor of valosin-containing protein in tumor-bearing dogs
AK LeBlanc, CN Mazcko, TM Fan, DM Vail, BK Flesner, JN Bryan, S Li, ...
Molecular cancer therapeutics 21 (10), 1510-1523, 2022
委任: US National Institutes of Health
Safety of TCMCB07, a melanocortin‐4 antagonist peptide, in dogs with naturally occurring cachexia
SM Axiak‐Bechtel, SB Leach, JR Newton‐Northup, RJ Milner, ...
Journal of veterinary internal medicine 37 (6), 2344-2355, 2023
委任: US National Institutes of Health
公開と助成金に関する情報は、コンピュータ プログラムによって自動的に決定されます